News
-
-
-
-
-
-
-
-
PRESS RELEASE
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present January 12 at the Annual Neuroscience Innovation Forum
Magdalena plans to file IND for new psychoactive drug in 2025 for mental health, focusing on ADHD and schizophrenia. Potential paradigm shift in plant-based drug development -
-